134 related articles for article (PubMed ID: 38070668)
1. Monitoring of ionized magnesium in hemodialysis patients: A useful tool to allow a personalized prescription of dialysate composition.
Bargnoux AS; Morena M; Rodriguez A; Courtais-Coulon C; Dupuy AM; Kuster N; Chalabi L; Cristol JP
Clin Chim Acta; 2024 Jan; 552():117687. PubMed ID: 38070668
[TBL] [Abstract][Full Text] [Related]
2. Improvements in Inflammation and Calcium Balance of Citrate versus Acetate as Dialysate Buffer in Maintenance Hemodialysis: A Unicentric, Cross-Over, Prospective Study.
Broseta JJ; López-Romero LC; Cerveró A; Devesa-Such R; Soldevila A; Bea-Granell S; Sánchez-Pérez P; Hernández-Jaras J
Blood Purif; 2021; 50(6):914-920. PubMed ID: 33535212
[TBL] [Abstract][Full Text] [Related]
3. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
[TBL] [Abstract][Full Text] [Related]
4. Impact of acetate- or citrate-acidified bicarbonate dialysate on ex vivo aorta wall calcification.
Villa-Bellosta R; Hernández-Martínez E; Mérida-Herrero E; González-Parra E
Sci Rep; 2019 Aug; 9(1):11374. PubMed ID: 31388059
[TBL] [Abstract][Full Text] [Related]
5. Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis.
van der Meulen J; Janssen MJ; Langendijk PN; Bouman AA; Oe PL
Clin Nephrol; 1992 Jan; 37(1):36-41. PubMed ID: 1541063
[TBL] [Abstract][Full Text] [Related]
6. Citrate vs. acetate dialysate on intradialytic heparin dose: A double blind randomized crossover study.
Leung KC; Tai DJ; Ravani P; Quinn RR; Scott-Douglas N; MacRae JM
Hemodial Int; 2016 Oct; 20(4):537-547. PubMed ID: 27325599
[TBL] [Abstract][Full Text] [Related]
7. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
8. Use of regional citrate anticoagulation with medium cut-off membrane: pilot report.
Vrečko MM; Pajek J; Buturović-Ponikvar J
BMC Nephrol; 2022 Oct; 23(1):346. PubMed ID: 36303108
[TBL] [Abstract][Full Text] [Related]
9. The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.
Zakharchenko M; Los F; Brodska H; Balik M
PLoS One; 2016; 11(7):e0158179. PubMed ID: 27391902
[TBL] [Abstract][Full Text] [Related]
10. Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes.
Gabutti L; Lucchini B; Marone C; Alberio L; Burnier M
BMC Nephrol; 2009 Mar; 10():7. PubMed ID: 19265544
[TBL] [Abstract][Full Text] [Related]
11. Advantages of the use of citrate over acetate as a stabilizer in hemodialysis fluid: A randomized ABC-treat study.
de Sequera P; Pérez-García R; Molina M; Álvarez-Fernández G; Muñoz-González RI; Mérida E; Camba MJ; Blázquez LA; Alcaide MP; Echarri R;
Nefrologia (Engl Ed); 2022; 42(3):327-337. PubMed ID: 36210622
[TBL] [Abstract][Full Text] [Related]
12. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
Morgera S; Haase M; Ruckert M; Krieg H; Kastrup M; Krausch D; Vargas-Hein O; Zuckermann-Becker H; Peters H; Pohlmeier R; Neumayer HH
Nephron Clin Pract; 2005; 101(4):c211-9. PubMed ID: 16155399
[TBL] [Abstract][Full Text] [Related]
13. Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility.
Grundström G; Christensson A; Alquist M; Nilsson LG; Segelmark M
BMC Nephrol; 2013 Oct; 14():216. PubMed ID: 24103587
[TBL] [Abstract][Full Text] [Related]
14. Changes of serum calcium, magnesium and parathyroid hormone induced by hemodialysis with citrate-enriched dialysis solution.
Šafránek R; Moučka P; Vávrová J; Palička V; Pavlíková L; Sulková SD
Kidney Blood Press Res; 2015; 40(1):13-21. PubMed ID: 25661822
[TBL] [Abstract][Full Text] [Related]
15. Effects of citrate dialysate in chronic dialysis: a multicentre randomized crossover study.
Schmitz M; Loke O; Fach B; Kalb K; Heering PJ; Meinke D; Rawer P; Galle J; Kozik-Jaromin J
Nephrol Dial Transplant; 2016 Aug; 31(8):1327-34. PubMed ID: 26442902
[TBL] [Abstract][Full Text] [Related]
16. [Non-pharmacological calcium metabolism control in patients undergoing hemodialysis].
Malberti F
G Ital Nefrol; 2009; 26(6):670-8. PubMed ID: 19918749
[TBL] [Abstract][Full Text] [Related]
17. Citrate dialysate does not induce oxidative stress or inflammation in vitro as compared to acetate dialysate.
Pérez-García R; Ramírez Chamond R; de Sequera Ortiz P; Albalate M; Puerta Carretero M; Ortega M; Ruiz Caro MC; Alcazar Arroyo R
Nefrologia; 2017; 37(6):630-637. PubMed ID: 29122211
[TBL] [Abstract][Full Text] [Related]
18. Dialysate made from dry chemicals using citric acid increases dialysis dose.
Ahmad S; Callan R; Cole JJ; Blagg CR
Am J Kidney Dis; 2000 Mar; 35(3):493-9. PubMed ID: 10692276
[TBL] [Abstract][Full Text] [Related]
19. Impact of Acetate versus Citrate Dialysates on Intermediary Metabolism-A Targeted Metabolomics Approach.
Broseta JJ; Roca M; Rodríguez-Espinosa D; López-Romero LC; Gómez-Bori A; Cuadrado-Payán E; Devesa-Such R; Soldevila A; Bea-Granell S; Sánchez-Pérez P; Hernández-Jaras J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232995
[TBL] [Abstract][Full Text] [Related]
20. Total serum and intraerythrocyte magnesium concentrations in hemodialysis patients using different dialysate solutions.
Kusic J; Markovic R; Andjelkovic Apostolovic M; Dragovic G
Magnes Res; 2020 May; 33(2):28-36. PubMed ID: 32900678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
